Starts in 15h 38m
Translational Medicine

Precision Oncology: From Biomarker to Bedside

Sunday, 1 November 2026
9:00 am - 10:45 am
Hall B (L2-HALL-B)

About

Three talks on liquid biopsy in practice: what the assays can and cannot tell a clinician, how trials are using them to escalate and de-escalate therapy, and what it costs.

Program

9:00 am

Circulating Tumour DNA as a Guide to Adjuvant Therapy

Priya Raman, Tasman University Medical School

35 min
9:35 am

Biomarker-Stratified Trials That Actually Answer the Question

Daniel Reyes, Southern Cross Clinical Trials Unit

35 min
10:10 am

Paying for Precision: The Economics of Molecular Testing

Kwame Mensah, Meridian Life Sciences Society

35 min

Q&A for Precision Oncology: From Biomarker to Bedside

Sign in to vote on questions.

Polls

Speakers
PR

Priya Raman

Associate Professor of Medical Oncology, Tasman University Medical School

View Profile →
DR

Daniel Reyes

Head of Biostatistics, Southern Cross Clinical Trials Unit

View Profile →
KM

Kwame Mensah

Director of Health Economics, Meridian Life Sciences Society

View Profile →
Details

Track

Translational Medicine

Duration

105 minutes

Room

Hall B

Related Sessions

Cell and Gene Therapy: Manufacturing to Market

Day 3 3:10 pm • Hall B

Single-Cell Atlases in Translational Immunology

Day 3 1:15 pm • Seminar Room 2.1

Pharmacogenomics at the Point of Prescribing

Day 3 11:10 am • Seminar Room 2.2